What are the orders for a voiding trial?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Voiding Trial Orders

A standard voiding trial should include removal of the Foley catheter, measurement of post-void residual after spontaneous voiding, and specific criteria for passing the trial based on voided volume relative to total bladder volume.

Components of Voiding Trial Orders

Pre-Trial Preparation

  • Ensure adequate hydration prior to the trial
  • Document baseline urinary symptoms
  • Consider initiating alpha-blockers (e.g., alfuzosin 10mg daily) at least 3 days before the trial for patients with urinary hesitancy 1

Catheter Removal Protocol

  • Remove Foley catheter on postoperative day 1 for most patients 2
  • Two main techniques for catheter removal:
    • Back-fill method: Fill bladder with 300cc saline before catheter removal (superior predictor of adequate bladder emptying) 3
    • Auto-fill method: Remove catheter and allow bladder to fill spontaneously 3

Monitoring Protocol

  • Instruct patient to void when feeling the urge
  • Measure and record:
    • Time of first void
    • Volume voided (using a measuring container/hat)
    • Post-void residual (PVR) via straight catheterization within 15 minutes of voiding 3
    • Force of urinary stream (patient self-report on scale 0-10) 4

Criteria for Passing Voiding Trial

  • Voided volume ≥ two-thirds (66%) of total bladder volume (voided volume + PVR) 3
  • OR voided volume > 50% of instilled volume (for back-fill method) 4
  • OR force of urinary stream ≥ 5 on a scale of 0-10 4
  • PVR < 100-150cc (clinically acceptable threshold)

Failed Voiding Trial Management

  • If initial trial fails:
    • Replace Foley catheter or initiate clean intermittent catheterization (CIC)
    • Schedule repeat voiding trial in 2-4 days 4
    • Consider pharmacological therapy with alpha-blockers if not already initiated 1

Post-Trial Monitoring

  • Monitor for symptoms of urinary retention or incomplete emptying
  • Consider second voiding trial within 3 hours after passing initial trial to confirm sustained voiding ability 5
  • Document final PVR before discharge

Special Considerations

Risk Factors for Failed Voiding Trial

  • Higher Charlson comorbidity index 6
  • Low maximum flow rate on preoperative uroflowmetry (< 15 cc/second) 5
  • Non-detrusor contraction voiding pattern 6
  • Nocturia 6

Location Options for Catheter Removal

  • Both home and office catheter removal show similar patient satisfaction rates (95% satisfaction) 4
  • Home catheter removal may be associated with lower rates of urinary tract infection (8.3% vs 26.3%) 4

Follow-Up Recommendations

  • Schedule follow-up within 1-2 weeks after successful voiding trial
  • Perform post-void residual measurement at follow-up visit 2
  • Monitor for symptoms of urinary tract infection, which occur more frequently in patients who fail initial voiding trials (20% vs 6%) 6

Documentation Requirements

  • Document voiding trial technique used
  • Record voided volumes and post-void residuals
  • Note criteria used to determine success or failure
  • Document patient education regarding signs/symptoms requiring medical attention

This structured approach to voiding trials provides clear criteria for success while accounting for individual patient factors that may affect voiding function.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.